| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 6.11e-05 | 343 | 101 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.70e-05 | 18 | 101 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 2.51e-04 | 5 | 101 | 2 | GO:0004749 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 3.75e-04 | 6 | 101 | 2 | GO:0016778 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.75e-04 | 28 | 101 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.00e-04 | 441 | 101 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.02e-04 | 129 | 101 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1E TRPM7 HCN1 PIEZO1 PKD1L1 GRIN2A PIEZO2 SCN4A ORAI3 TMCO3 CHP1 | 5.33e-04 | 664 | 101 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.34e-04 | 459 | 101 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.86e-04 | 465 | 101 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 6.95e-04 | 8 | 101 | 2 | GO:0004169 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.61e-04 | 37 | 101 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.02e-03 | 151 | 101 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19A KATNAL2 MYO1E DNAH2 DNAH7 DDX10 HELZ POLQ DDX39B DNAH11 | 1.10e-03 | 614 | 101 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | helicase activity | 1.25e-03 | 158 | 101 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | channel activity | 1.37e-03 | 525 | 101 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.39e-03 | 526 | 101 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19A KATNAL2 CRACR2A MYO1E DNAH2 DNAH7 RGS12 DDX10 POLQ DDX39B DNAH11 | 1.86e-03 | 775 | 101 | 11 | GO:0017111 |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 2.29e-04 | 5 | 101 | 2 | GO:0002189 | |
| GeneOntologyCellularComponent | cell projection membrane | 2.43e-04 | 431 | 101 | 9 | GO:0031253 | |
| Domain | PIEZO | 2.84e-05 | 2 | 100 | 2 | PF15917 | |
| Domain | Piezo | 2.84e-05 | 2 | 100 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 2.84e-05 | 2 | 100 | 2 | PF12166 | |
| Domain | Piezo_RRas-bd_dom | 2.84e-05 | 2 | 100 | 2 | IPR031334 | |
| Domain | Piezo_dom | 2.84e-05 | 2 | 100 | 2 | IPR031805 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-05 | 14 | 100 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-05 | 14 | 100 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-05 | 14 | 100 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-05 | 14 | 100 | 3 | PF08393 | |
| Domain | MT | 5.19e-05 | 14 | 100 | 3 | PF12777 | |
| Domain | AAA_8 | 5.19e-05 | 14 | 100 | 3 | PF12780 | |
| Domain | DHC_fam | 6.47e-05 | 15 | 100 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 6.47e-05 | 15 | 100 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.47e-05 | 15 | 100 | 3 | IPR004273 | |
| Domain | PRPP_SYNTHASE | 8.48e-05 | 3 | 100 | 2 | PS00114 | |
| Domain | PRib_PP_synth_CS | 8.48e-05 | 3 | 100 | 2 | IPR000842 | |
| Domain | ZF_ZZ_2 | 1.15e-04 | 18 | 100 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.15e-04 | 18 | 100 | 3 | PS01357 | |
| Domain | ZZ | 1.15e-04 | 18 | 100 | 3 | PF00569 | |
| Domain | Znf_ZZ | 1.36e-04 | 19 | 100 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.36e-04 | 19 | 100 | 3 | SM00291 | |
| Domain | Pribosyltran_N | 2.81e-04 | 5 | 100 | 2 | PF13793 | |
| Domain | Pribosyl_synth | 2.81e-04 | 5 | 100 | 2 | PF14572 | |
| Domain | Rib-P_diPkinase | 2.81e-04 | 5 | 100 | 2 | IPR005946 | |
| Domain | Pribosyltran_N | 2.81e-04 | 5 | 100 | 2 | IPR029099 | |
| Domain | EF-hand_dom_typ1 | 4.20e-04 | 6 | 100 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 4.20e-04 | 6 | 100 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 4.20e-04 | 6 | 100 | 2 | PF09068 | |
| Domain | EF-hand_3 | 4.20e-04 | 6 | 100 | 2 | PF09069 | |
| Domain | ARM-like | 6.22e-04 | 270 | 100 | 7 | IPR011989 | |
| Domain | DEAD/DEAH_box_helicase_dom | 6.34e-04 | 73 | 100 | 4 | IPR011545 | |
| Domain | DEAD | 6.34e-04 | 73 | 100 | 4 | PF00270 | |
| Domain | DHC_N1 | 7.78e-04 | 8 | 100 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.78e-04 | 8 | 100 | 2 | IPR013594 | |
| Domain | Q_MOTIF | 1.01e-03 | 37 | 100 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 1.01e-03 | 37 | 100 | 3 | IPR014014 | |
| Domain | EF-hand_7 | 1.12e-03 | 85 | 100 | 4 | PF13499 | |
| Domain | Tyr_kinase_cat_dom | 1.28e-03 | 88 | 100 | 4 | IPR020635 | |
| Domain | TyrKc | 1.28e-03 | 88 | 100 | 4 | SM00219 | |
| Domain | Pribosyltran | 1.51e-03 | 11 | 100 | 2 | PF00156 | |
| Domain | EF_hand_dom | 1.55e-03 | 232 | 100 | 6 | IPR002048 | |
| Domain | PRTase-like | 1.81e-03 | 12 | 100 | 2 | IPR029057 | |
| Domain | PRibTrfase_dom | 1.81e-03 | 12 | 100 | 2 | IPR000836 | |
| Domain | - | 1.81e-03 | 12 | 100 | 2 | 3.40.50.2020 | |
| Domain | PROTEIN_KINASE_TYR | 1.83e-03 | 97 | 100 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.83e-03 | 97 | 100 | 4 | IPR008266 | |
| Domain | P-loop_NTPase | DDX19A KATNAL2 MYO1E DNAH2 LRRK1 DNAH7 DDX10 HELZ CAMTA1 POLQ DDX39B DNAH11 | 1.90e-03 | 848 | 100 | 12 | IPR027417 |
| Domain | - | DDX19A KATNAL2 MYO1E DNAH2 LRRK1 DNAH7 DDX10 HELZ POLQ DDX39B DNAH11 | 2.14e-03 | 746 | 100 | 11 | 3.40.50.300 |
| Domain | ARM-type_fold | 2.31e-03 | 339 | 100 | 7 | IPR016024 | |
| Domain | ATPase_dyneun-rel_AAA | 2.48e-03 | 14 | 100 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.48e-03 | 14 | 100 | 2 | PF07728 | |
| Domain | Helicase_C | 2.62e-03 | 107 | 100 | 4 | PF00271 | |
| Domain | HELICc | 2.62e-03 | 107 | 100 | 4 | SM00490 | |
| Domain | Helicase_C | 2.71e-03 | 108 | 100 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.80e-03 | 109 | 100 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.80e-03 | 109 | 100 | 4 | PS51192 | |
| Domain | DEXDc | 2.80e-03 | 109 | 100 | 4 | SM00487 | |
| Domain | - | 2.80e-03 | 261 | 100 | 6 | 1.10.238.10 | |
| Domain | Helicase_ATP-bd | 2.89e-03 | 110 | 100 | 4 | IPR014001 | |
| Domain | Ion_trans_dom | 3.29e-03 | 114 | 100 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.29e-03 | 114 | 100 | 4 | PF00520 | |
| Domain | EF-hand-dom_pair | 4.46e-03 | 287 | 100 | 6 | IPR011992 | |
| Domain | Pkinase_Tyr | 5.11e-03 | 129 | 100 | 4 | PF07714 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO1E PHF12 PIEZO1 POLR2A LRRK1 KAT2A CNTROB MST1R STX4 PSME4 SCARB1 RIC8A NLGN2 HERC2 GCN1 | 1.05e-06 | 1105 | 104 | 15 | 35748872 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX19A XRN2 ACADVL POLR2A URB2 DDX10 CKB SNRPGP15 SF3B3 STX4 BBS7 HERC2 GCN1 DDX39B | 2.29e-06 | 1024 | 104 | 14 | 24711643 |
| Pubmed | DTNA POLR2A EYA1 CNTROB PPP4R3A FBXL16 HELZ SSH2 HERC2 DMD PSMD14 GCN1 CAP2 PPP6R3 | 3.02e-06 | 1049 | 104 | 14 | 27880917 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 3.78e-06 | 303 | 104 | 8 | 25056061 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 4.79e-06 | 313 | 104 | 8 | 38270169 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPS2 DDX19A MYO1E POLR2A NARS1 PPP4R3A CKB PSME4 RIC8A PSMD14 GCN1 KYNU DDX39B CAP2 PPP6R3 PRPS1 | 6.67e-06 | 1455 | 104 | 16 | 22863883 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L DDX19A DTNA EYA1 PPP4R3A CKB HELZ TTC13 DMD PSMD14 GCN1 PPP6R3 PRPS1 | 7.01e-06 | 974 | 104 | 13 | 28675297 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX19A XRN2 POLR2A NARS1 URB2 DPM1 RIC8A PSMD14 GCN1 DDX39B LCMT1 | 8.77e-06 | 704 | 104 | 11 | 29955894 |
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 8.86e-06 | 2 | 104 | 2 | 21299953 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18209063 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18409517 | ||
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 8.86e-06 | 2 | 104 | 2 | 38395992 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37820892 | ||
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 8.86e-06 | 2 | 104 | 2 | 39251883 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37975162 | ||
| Pubmed | Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle. | 8.86e-06 | 2 | 104 | 2 | 11316257 | |
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 8.86e-06 | 2 | 104 | 2 | 28636944 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23043099 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25037583 | ||
| Pubmed | PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. | 8.86e-06 | 2 | 104 | 2 | 33493137 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30324494 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21056836 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30745454 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 8.86e-06 | 2 | 104 | 2 | 36717101 | |
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 8.86e-06 | 2 | 104 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 8.86e-06 | 2 | 104 | 2 | 27743844 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2537655 | ||
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 8.86e-06 | 2 | 104 | 2 | 38928429 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 8.86e-06 | 2 | 104 | 2 | 26008989 | |
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 8.86e-06 | 2 | 104 | 2 | 20813920 | |
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 8.86e-06 | 2 | 104 | 2 | 32142647 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 34464353 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPS2 DDX19A XRN2 ACADVL NARS1 DPM1 ADD1 DDX10 SNRPGP15 SF3B3 HELZ PSMD14 GCN1 DDX39B PRPS1 | 8.91e-06 | 1318 | 104 | 15 | 30463901 |
| Pubmed | 9.23e-06 | 14 | 104 | 3 | 9373155 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PRPS2 VPS13C WDR81 URB2 RGS12 CKB STX4 TMCO3 HERC2 CAP2 CHP1 | 1.07e-05 | 719 | 104 | 11 | 35337019 |
| Pubmed | 1.51e-05 | 103 | 104 | 5 | 10819331 | ||
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 1.71e-05 | 17 | 104 | 3 | 23502783 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.94e-05 | 498 | 104 | 9 | 36634849 | |
| Pubmed | XRN2 POLR2A ADD1 PPP4R3A SF3B3 RIC8A PSMD14 GCN1 DDX39B PPP6R3 | 2.24e-05 | 638 | 104 | 10 | 33239621 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PRPS2 DDX19A XRN2 POLR2A DPM1 MIDN SF3B3 PSME4 PSMD14 GCN1 DDX39B PPP6R3 CHP1 PRPS1 | 2.31e-05 | 1257 | 104 | 14 | 37317656 |
| Pubmed | SEL1L XRN2 MYO1E NARS1 HPSE DPM1 CKB SF3B3 STX4 RWDD1 PSMD14 GCN1 PPP6R3 CHP1 PRPS1 | 2.51e-05 | 1440 | 104 | 15 | 30833792 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 2.56e-05 | 516 | 104 | 9 | 36610398 | |
| Pubmed | Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. | 2.65e-05 | 3 | 104 | 2 | 9356463 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 25816608 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 1314091 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9499411 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9366267 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 16540561 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 25158611 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 30726728 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15565158 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 38124148 | ||
| Pubmed | Interaction of α-catulin with dystrobrevin contributes to integrity of dystrophin complex in muscle. | 2.65e-05 | 3 | 104 | 2 | 22577143 | |
| Pubmed | Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. | 2.65e-05 | 3 | 104 | 2 | 10559919 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17135300 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 31408461 | ||
| Pubmed | beta-dystrobrevin, a member of the dystrophin-related protein family. | 2.65e-05 | 3 | 104 | 2 | 9419360 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 28364093 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 29521261 | ||
| Pubmed | PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex. | 2.65e-05 | 3 | 104 | 2 | 30361375 | |
| Pubmed | Piezo1, a mechanically activated ion channel, is required for vascular development in mice. | 2.65e-05 | 3 | 104 | 2 | 24958852 | |
| Pubmed | Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma. | 2.65e-05 | 3 | 104 | 2 | 32391636 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 37321223 | ||
| Pubmed | GCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression. | 2.65e-05 | 3 | 104 | 2 | 35024765 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 38743566 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10719885 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 1962753 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 35650194 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 26175007 | ||
| Pubmed | 2.72e-05 | 653 | 104 | 10 | 22586326 | ||
| Pubmed | SEL1L KATNAL2 FBLL1 MAN2A1 PHF12 PIEZO1 POLR2A URB2 KAT2A DDX10 HELZ HERC2 CSTF2T PPP6R3 CHP1 | 3.92e-05 | 1497 | 104 | 15 | 31527615 | |
| Pubmed | SEL1L TRPM7 PHF12 NARS1 KAT2A DPM1 SF3B3 HELZ RIC8A SSH2 GCN1 PPP6R3 LCMT1 CHP1 | 4.18e-05 | 1327 | 104 | 14 | 32694731 | |
| Pubmed | 4.29e-05 | 128 | 104 | 5 | 30995482 | ||
| Pubmed | 4.97e-05 | 132 | 104 | 5 | 26439863 | ||
| Pubmed | 5.02e-05 | 24 | 104 | 3 | 32186512 | ||
| Pubmed | Mechanosensory hair cells express two molecularly distinct mechanotransduction channels. | 5.29e-05 | 4 | 104 | 2 | 27893727 | |
| Pubmed | Piezo mechanosensory channels regulate centrosome integrity and mitotic entry. | 5.29e-05 | 4 | 104 | 2 | 36574677 | |
| Pubmed | Syntrophin binds to an alternatively spliced exon of dystrophin. | 5.29e-05 | 4 | 104 | 2 | 7844150 | |
| Pubmed | Piezo2 regulates colonic mechanical sensitivity in a sex specific manner in mice. | 5.29e-05 | 4 | 104 | 2 | 37061508 | |
| Pubmed | XPC is an RNA polymerase II cofactor recruiting ATAC to promoters by interacting with E2F1. | 5.29e-05 | 4 | 104 | 2 | 29973595 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 18057022 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 36563677 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 30037999 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 29790927 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9701558 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 7849396 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 35302846 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 34852225 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 35732741 | ||
| Pubmed | Differential association of syntrophin pairs with the dystrophin complex. | 8.80e-05 | 5 | 104 | 2 | 9214383 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 1360279 | ||
| Pubmed | Sarcolemma-localized nNOS is required to maintain activity after mild exercise. | 8.80e-05 | 5 | 104 | 2 | 18953332 | |
| Pubmed | Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity. | 8.80e-05 | 5 | 104 | 2 | 36323321 | |
| Pubmed | Ordered disorder of the astrocytic dystrophin-associated protein complex in the norm and pathology. | 8.80e-05 | 5 | 104 | 2 | 24014171 | |
| Pubmed | PRPS2 CACNA1E ACADVL ZSWIM5 DTNA DNAH2 KAT2A SF3B3 SCN4A DMD POLQ DDX39B LCMT1 PRPS1 | 1.01e-04 | 1442 | 104 | 14 | 35575683 | |
| Pubmed | 1.16e-04 | 83 | 104 | 4 | 11114734 | ||
| Pubmed | Myospryn is a novel binding partner for dysbindin in muscle. | 1.32e-04 | 6 | 104 | 2 | 14688250 | |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 24855946 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 20418871 | ||
| Cytoband | 17p13.1 | 3.13e-07 | 118 | 104 | 6 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.48e-05 | 346 | 104 | 7 | chr17p13 | |
| GeneFamily | Dyneins, axonemal | 3.05e-05 | 17 | 66 | 3 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.65e-05 | 18 | 66 | 3 | 91 | |
| GeneFamily | EF-hand domain containing | 1.46e-04 | 219 | 66 | 6 | 863 | |
| GeneFamily | DEAD-box helicases | 4.82e-04 | 42 | 66 | 3 | 499 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 163 | 103 | 6 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 163 | 103 | 6 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.58e-06 | 185 | 103 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.72e-06 | 186 | 103 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.02e-06 | 188 | 103 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.17e-06 | 189 | 103 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-06 | 191 | 103 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-06 | 191 | 103 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-06 | 191 | 103 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 6.56e-06 | 197 | 103 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 148 | 103 | 5 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 148 | 103 | 5 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 154 | 103 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 154 | 103 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-05 | 155 | 103 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-05 | 155 | 103 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.43e-05 | 159 | 103 | 5 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.43e-05 | 159 | 103 | 5 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 172 | 103 | 5 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.12e-05 | 173 | 103 | 5 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 176 | 103 | 5 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-05 | 178 | 103 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 178 | 103 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-05 | 179 | 103 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.18e-05 | 180 | 103 | 5 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.51e-05 | 182 | 103 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.51e-05 | 182 | 103 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-05 | 184 | 103 | 5 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-05 | 184 | 103 | 5 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-05 | 184 | 103 | 5 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.86e-05 | 184 | 103 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-05 | 184 | 103 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.04e-05 | 185 | 103 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.40e-05 | 187 | 103 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.40e-05 | 187 | 103 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.78e-05 | 189 | 103 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.78e-05 | 189 | 103 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.78e-05 | 189 | 103 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.78e-05 | 189 | 103 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 7.78e-05 | 189 | 103 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 7.78e-05 | 189 | 103 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.78e-05 | 189 | 103 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-05 | 190 | 103 | 5 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-05 | 190 | 103 | 5 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.98e-05 | 190 | 103 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.18e-05 | 191 | 103 | 5 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.18e-05 | 191 | 103 | 5 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.18e-05 | 191 | 103 | 5 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.18e-05 | 191 | 103 | 5 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.18e-05 | 191 | 103 | 5 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.18e-05 | 191 | 103 | 5 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.18e-05 | 191 | 103 | 5 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.18e-05 | 191 | 103 | 5 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.18e-05 | 191 | 103 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.18e-05 | 191 | 103 | 5 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.18e-05 | 191 | 103 | 5 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 8.18e-05 | 191 | 103 | 5 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 8.38e-05 | 192 | 103 | 5 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-05 | 192 | 103 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-05 | 192 | 103 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 8.38e-05 | 192 | 103 | 5 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.80e-05 | 194 | 103 | 5 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-05 | 194 | 103 | 5 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-05 | 194 | 103 | 5 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.80e-05 | 194 | 103 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.01e-05 | 195 | 103 | 5 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.01e-05 | 195 | 103 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 195 | 103 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 195 | 103 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | 44f67437ea65d530133a0240b17f9860d9cc0e99 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.59e-05 | 100 | 102 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 8.30e-05 | 206 | 102 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.74e-04 | 80 | 102 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | MRGPRD POLR2A GRIN2A EYA1 CMIP FBXL16 STX4 SCARB1 SCN4A TBC1D29P GCN1 PPP6R3 | 4.39e-04 | 1106 | 102 | 12 | EFO_0021796 |
| Disease | Essential hypertension | 5.23e-04 | 10 | 102 | 2 | cv:C0085580 | |
| Disease | Essential hypertension, genetic | 5.23e-04 | 10 | 102 | 2 | cv:CN305331 | |
| Disease | HYPERTENSION, ESSENTIAL | 5.23e-04 | 10 | 102 | 2 | 145500 | |
| Disease | diastolic blood pressure, systolic blood pressure | 5.33e-04 | 670 | 102 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | Essential Hypertension | 7.64e-04 | 12 | 102 | 2 | C0085580 | |
| Disease | age at first birth measurement | 8.13e-04 | 120 | 102 | 4 | EFO_0009101 | |
| Disease | non-high density lipoprotein cholesterol measurement | 8.29e-04 | 713 | 102 | 9 | EFO_0005689 | |
| Disease | smoking cessation | 9.46e-04 | 325 | 102 | 6 | EFO_0004319 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.19e-03 | 60 | 102 | 3 | EFO_0022330 | |
| Disease | HDL cholesterol change measurement, physical activity | 1.31e-03 | 62 | 102 | 3 | EFO_0003940, EFO_0007805 | |
| Disease | serum non-albumin protein measurement | 1.62e-03 | 361 | 102 | 6 | EFO_0004568 | |
| Disease | physical activity measurement | 1.64e-03 | 245 | 102 | 5 | EFO_0008002 | |
| Disease | adiponectin measurement | 1.68e-03 | 146 | 102 | 4 | EFO_0004502 | |
| Disease | dehydroepiandrosterone sulphate measurement | 1.71e-03 | 68 | 102 | 3 | EFO_0007001 | |
| Disease | essential hypertension (is_implicated_in) | 1.75e-03 | 18 | 102 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | susceptibility to mononucleosis measurement | 1.78e-03 | 69 | 102 | 3 | EFO_0008403 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.95e-03 | 19 | 102 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Infiltrating duct carcinoma of female breast | 2.38e-03 | 21 | 102 | 2 | C3165106 | |
| Disease | amino acid measurement | 2.46e-03 | 678 | 102 | 8 | EFO_0005134 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.75e-03 | 276 | 102 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.91e-03 | 82 | 102 | 3 | EFO_0005658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IGTFLEELMQMLIQM | 1001 | Q14146 | |
| LLMNSEQRINRIMGF | 36 | P49069 | |
| MDLILNRMDYLQVGV | 1 | Q8IWZ6 | |
| VLMMANREVVNTELG | 1361 | Q9Y6Y1 | |
| LIIITFQEQGDKMME | 1421 | Q15878 | |
| MLEQLDMRRDVQEIF | 201 | Q13838 | |
| ALRGNQTMVEILCLM | 576 | Q8IY22 | |
| MLGLAEVRQEIMNRV | 1006 | Q96DT5 | |
| EEAQFRMLMDRLGAQ | 156 | Q9BSW2 | |
| QRVMVGDLEDINEMI | 2496 | P11532 | |
| EVELAIIMQRLDMDG | 116 | Q9BXU9 | |
| GYVFQMEMIVRARQL | 206 | O60762 | |
| MEMIVRARQLNYTIG | 211 | O60762 | |
| RLLGMVVDVENLFMS | 171 | Q92830 | |
| LMNSAIIEMFEFIRV | 596 | Q6IN85 | |
| LSGFAMVAMVEVQLE | 71 | Q9BRQ5 | |
| ANLGMIVLIRMDYQL | 41 | Q8NH69 | |
| RQMLEVILAIGNFMN | 796 | Q86T65 | |
| NSGQIEVIMDRRLMQ | 946 | Q16706 | |
| QMVVDGVKLLIEMEQ | 351 | P12277 | |
| QPEEVQFRRLQALMM | 1486 | Q38SD2 | |
| MLAMNRQGSIIFLTV | 106 | Q8TDS4 | |
| IVVQLMEMGFSRRNI | 2461 | O95714 | |
| EMELIELGQQIRMNL | 66 | Q9NP86 | |
| AQINMFGREIVEMLL | 2911 | Q5CZC0 | |
| MANMQGLVERLERAV | 1 | P40123 | |
| RMLIGMVDVIFADVA | 236 | A6NHQ2 | |
| MAIGVRLQVQLAPVM | 496 | Q02817 | |
| FIGMNSEMRELAAVV | 226 | Q8IYT4 | |
| VSLGLRMEEMIFNLA | 356 | Q99502 | |
| FRVDMVQAALIMGVL | 176 | Q8TDS7 | |
| QRQAAEVMGRLMEIY | 1191 | Q92616 | |
| ENLIRMGMAGLVLVF | 446 | Q6PI73 | |
| DILGLAMQNLVVLQM | 941 | Q6IE36 | |
| VFDFGLEPVLMQRVM | 366 | P42694 | |
| QMIEQIQFVKLFGMV | 301 | Q14541 | |
| LFGMVKIDNLLQEML | 311 | Q14541 | |
| LSARMGIEVVMRQVF | 371 | Q9Y251 | |
| MITDVQLAIFANMLG | 1 | P0C6T2 | |
| LASAVVRIFNLIGMM | 291 | O60741 | |
| FEMIMLGRLLVGVNA | 121 | Q9BYW1 | |
| LEVFMETQMFRGFIQ | 946 | Q9ULE3 | |
| EEARMILQQDLVEMG | 881 | O75417 | |
| MVLRMNAQDVRALGI | 961 | P29322 | |
| VIQKEFIMGLFDRMV | 1776 | Q8WXX0 | |
| QESRRELMVQLEGLM | 536 | Q9Y4J8 | |
| NAFMLLMRNIVRVVV | 576 | Q53GD3 | |
| ALLQAQVVMRIMDPE | 171 | Q9H0L4 | |
| RILDMGFADTMNAVI | 226 | Q13206 | |
| NMFERNIVDMVGLFI | 381 | Q9H069 | |
| LLSGEMMVEQRAAVI | 361 | Q9NUU7 | |
| AQVEIVMQAVMILRG | 3121 | Q9P225 | |
| ILMQQGEFLNYDMLI | 366 | Q8NFZ4 | |
| FVDQEEMIGSVLMLR | 1361 | Q8TDX9 | |
| AMQQRIGEIVAEMDV | 31 | Q5SRE7 | |
| IFEMESVRGQLQTML | 96 | Q8N137 | |
| ERLLQMVFGAMVLLV | 96 | Q9BT04 | |
| VIDAFRLINANMMVL | 156 | O00487 | |
| LQQMQEAELRLLEGM | 16 | P07332 | |
| LALRVGDHMMFVQLQ | 141 | Q504T8 | |
| EVMLEQMQGVVRLEL | 211 | Q8N461 | |
| RLEENLIILSQVMGM | 256 | Q9NYV8 | |
| VFLMVMVIGNLVVLN | 781 | P35499 | |
| LVTQDVQLGLFMAVM | 421 | Q6UWJ1 | |
| VDVQLNNRHMMIRGE | 226 | O43776 | |
| IRDMFTQLDMDQLLG | 726 | Q9UBV2 | |
| VNMGDRFGQIMIENL | 231 | Q9UIC8 | |
| MGVSEEMQARALVLQ | 266 | Q16647 | |
| RAFMDVNGEIEINML | 731 | Q96QT6 | |
| LGERAFMNRTVGEIM | 166 | Q8WTV0 | |
| FLATEVEMQGEMINR | 226 | Q12846 | |
| NNMLREIRMLAGEVL | 66 | Q7Z745 | |
| EFMGVNMDVIRALLI | 301 | Q9NPQ8 | |
| FGLIQEKLARMVMLQ | 376 | P49748 | |
| QIGEQEFEALMRMLD | 371 | P35611 | |
| LQVLRMMVGVNISDE | 136 | Q99653 | |
| LALVSMGFAILNMIQ | 111 | A0PK11 | |
| LEEMFQEMLQRLGRV | 151 | Q8N7C3 | |
| MGLAALEVMQAVQRT | 531 | Q8NBP0 | |
| ALEVALMGLGQQRLM | 661 | Q9P217 | |
| LLNVALELGLQVMRM | 861 | Q9P217 | |
| DMRNLATIFLAVVMA | 351 | Q8IUR5 | |
| RVVEEMQSGGIFNMI | 136 | O14924 | |
| KEFIDNEMIVILGQM | 291 | Q76I76 | |
| NMVLRILGFLVDTAM | 511 | Q6ZV50 | |
| GEINDNLMELLIMIN | 61 | P11908 | |
| RDVFLERGEVMNLLM | 551 | P24928 | |
| NIGMVEIRGNSIIML | 56 | A8MWD9 | |
| LQRVQMIMLAVGEVE | 386 | Q9H0D6 | |
| MVLIQFGTMVVDRAL | 2236 | Q9H5I5 | |
| MMSEELVLGILLQDF | 181 | Q5BVD1 | |
| FMVLIQEMALKIDQG | 3261 | Q709C8 | |
| MLFEVANLREGMSVL | 171 | Q9HCJ6 | |
| LEISMMQGFARLLIN | 111 | Q14997 | |
| LFRVRMQGQEAVLAM | 701 | Q15393 | |
| LEGEQMLMLITSIAF | 41 | Q9UFV1 | |
| ELGDFLREVSVMMNL | 161 | Q13470 | |
| GEINDNLMELLIMIN | 61 | P60891 | |
| LMAVNVIGQRMNFLV | 1001 | Q92508 | |
| LLALQAEENLGMVMI | 86 | Q9H446 | |
| LMELNSIGVILNMFF | 366 | Q5H9R7 | |
| EMQQVEAFLREGLLM | 1121 | Q04912 | |
| VMLENFRNLMLVRDG | 36 | Q96NJ3 | |
| QAMLDALVMDRVAFV | 441 | Q96QT4 | |
| MQALGVLLAEMVFAT | 771 | Q562E7 | |
| LQLHGLNIEESMRMI | 176 | Q16719 | |
| RNRDVLFMDLIELMQ | 521 | Q12965 | |
| AADFIQRGSLIMDMV | 921 | Q12879 |